Neuroglobin: A New Possible Marker of Estrogen-Responsive Breast Cancer

Neuroglobin: A New Possible Marker of Estrogen-Responsive Breast Cancer

The expression of the α-subtype of Estrogen Receptor (ERα) characterizes most breast cancers (more than 75%), for which endocrine therapy is the mainstay for their treatment. However, a high percentage of ERα+ breast cancers are de novo or acquired resistance to endocrine therapy, and the definition...

Full description

Bibliographic Details
Main Authors: Virginia Solar Fernandez, Marco Fiocchetti, Manuela Cipolletti, Marco Segatto, Paolo Cercola, Annalisa Massari, Sabrina Ghinassi, Francesco Cavaliere, Maria Marino
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Cells
Subjects:
AKT
breast cancer survival
ductal infiltrating adenocarcinoma
estrogen receptor α
neuroglobin
tumor microenvironment
Online Access:https://www.mdpi.com/2073-4409/10/8/1986

Internet

https://www.mdpi.com/2073-4409/10/8/1986

Similar Items